Net profit of Cyient rose 15.93% to Rs 189.20 crore in the quarter ended March 2024 as against Rs 163.20 crore during the previous quarter ended March 2023. Sales rose 6.25% to Rs 1860.80 crore in the quarter ended March 2024 as against Rs 1751.40 crore during the previous quarter ended March 2023.For the full year,net profit rose 32.74% to Rs 682.80 crore in the year ended March 2024 as against Rs 514.40 crore during the previous year ended March 2023. Sales rose 18.81% to Rs 7147.20 crore in the year ended March 2024 as against Rs 6015.90 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales1860.801751.40 6 7147.206015.90 19 OPM %18.0218.39 -18.2316.67 - PBDT326.30296.30 10 1252.70984.50 27 PBT259.10223.70 16 986.00727.90 35 NP189.20163.20 16 682.80514.40 33 Powered by Capital Market - Live News

Cyient will hold a meeting of the Board of Directors of the Company on 25 April 2024.Powered by Capital Market - Live News

Cyient has allotted 57,051 equity shares under ASOP 2015 & ARSU 2020.Powered by Capital Market - Live News

Cyient announced that �CYIENT DLM INC� has been incorporated under General Corporation Law of the State of Delaware, USA as a wholly owned subsidiary of Cyient DLM, which is a subsidiary of Cyient. Cyient DLM Inc will be a step down subsidiary of the Company. Powered by Capital Market - Live News

Cyient announced its membership with the Massachusetts Medical Device Industry Council (MassMedic), the largest regional MedTech association in the United States. This partnership signifies a strategic move by Cyient to deepen its commitment to the healthcare sector, leveraging its extensive expertise in engineering and digital technologies to drive forward MedTech innovation. Through this collaboration, Cyient aims to support the MedTech community by enhancing product development, testing, and compliance with regulatory standards. Cyient`s proven track record in delivering end-to-end solutions will empower MedTech companies to navigate the complexities of the healthcare market more efficiently. As part of the partnership, Cyient and MassMedic will launch a series of initiatives aimed at addressing critical challenges in the MedTech sector. These will include collaborative workshops, thought leadership sessions, and innovation-driven projects designed to foster technological advancements and encourage knowledge sharing among industry leaders.Powered by Capital Market - Live News